Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BLOOMFIELD, Conn. , Oct. 9, 2023 /PRNewswire/ -- American families are struggling to overcome mental health issues exacerbated by the pandemic as parents need more support from employers and communities to help them do so, according to a report from The Cigna Group.

New Report Urges Collaborative, Community Approach to Combat the U.S. Mental Health Crisis

Automatic Data Processing

Chevron

PepsiCo

Pfizer

Truist Financial

Verizon

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields just over 3%, we present two other groups of five DGI stocks each, with the goal of moderate to high yields.

5 Relatively Safe And Cheap Dividend Stocks To Invest In - October 2023

Easily shared, standardized measures will enhance patient outcomes while driving consistency for clinicians 44,000 providers will participate in initial launch of program BLOOMFIELD, Conn. , Oct. 6, 2023 /PRNewswire/ -- To better align on quality care and reimburse providers for delivering improved health outcomes, Evernorth Health Services is launching an innovative measurement-based care program for its behavioral health network.

Evernorth Introduces Innovative Behavioral Health Measurement-Based Care Program, Reinforcing Commitment to Health and Value While Improving Provider Experience

Cigna (CI) declares the availability of a varied set of health plans across new counties in 2024. It, thereby, places intensified focus on growing its Medicare business.

Cigna (CI) Unveils 2024 Expansion Plans, Eyes Membership Growth

AbbVie

Amphenol

Broadcom

Bank of New York Mellon

CBRE Group

Elevance Health Inc

KLA-Tencor

Eli Lilly

Lam Research

Microchip Technology

Mettler-Toledo

PPG Industries

Why settle for stocks limping to the finish line? Some investors found S&P 500 stocks that finish the year on a high note.

There's Still Time To Own 13 Stocks That Finish The Year Strong

Health insurance provider The Cigna Group will pay more than $172 million over claims it gave the federal government inaccurate Medicare Advantage diagnoses codes in order to inflate reimbursement.

Cigna to pay over $172 million to settle claims over Medicare Advantage reimbursement

Founded to help address the national state of emergency in children's mental health, Bend Health is now available as an in-network benefit through Evernorth Health Services MADISON, Wis. , Oct. 2, 2023 /PRNewswire/ -- Bend Health, Inc. ("Bend"), a leading national, virtual pediatric behavioral care provider, today announced its coaching, therapy and psychiatry services are available as an in-network benefit through Evernorth Health Services, the pharmacy, care and benefits solutions division of The Cigna Group (NYSE: CI).

Bend Health Joins Evernorth's Behavioral Health Network, Expanding Access to Pediatric and Teen Mental Health Care

$0 premium plan offered in every service market, and all plans feature dental, vision, fitness, meals, and enhanced hearing benefits Expanded Medicare Advantage service areas for both Medicare and dual eligible beneficiaries, reaching an additional 2.3 million potential customers Plans available for every lifestyle, including choice of Medicare Advantage plans, Medicare Supplement plans, and standalone Prescription Drug Plans NASHVILLE, Tenn. , Oct. 2, 2023 /PRNewswire/ -- Cigna Healthcare℠ will offer affordable, quality Medicare Advantage (MA) plans across 29 states in 2024.

Cigna Healthcare Expands 2024 Medicare Advantage Plans Offering Customers More Variety and Value

Bank of America

Discover

Domino's Pizza

Monolithic Power Systems

MSCI

Charles Schwab

Sirius XM Holdings Inc

SS&C Technologies Hlds

Skyworks Solutions

Tractor Supply

Texas Instruments

Vanguard Dividend Appreciation ETF

W. R. Berkley

Zoetis

September has historically been a bad month for equities, with the SPDR S&P 500 Trust ETF and Vanguard's Dividend Appreciation ETF both posting losses during the last 4 Septembers. The top 15 dividend growth stocks for October offer an average dividend yield of 1.94% and appear to be about 35% undervalued based on dividend yield theory. Since inception, September 2020, the watchlist is outperforming VIG by 2.92% and SPY by 2.34%, on an annualized basis.

My Top 15 High Growth Dividend Stocks For October 2023

Cigna stock gets a Buy rating today. Strengths: dividends, valuation, revenue growth, net income & EPS, share price vs. moving average, capital & liquidity. Offsetting factors:  price performance vs S&P 500.

Cigna: Buy Rating Driven By Undervaluation And Revenue Growth

Health insurer Cigna Group says it has reached a settlement with the United States over claims it overcharged the government's Medicare Advantage program by making it appear patients were more ill than they actually were.

Cigna Group announces settlement with US on claims it overcharged Medicare Advantage program

BLOOMFIELD, Conn. , Sept. 29, 2023 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) announced it has fully resolved pending legal matters related to certain past Medicare Advantage risk adjustment practices.

The Cigna Group Affirms Commitment to Medicare Advantage Customers; Resolves Allegations Related to Industry Risk Adjustment Practices

Charter Communications

Expedia

Generac Holdings

In a dramatic return to the financial spotlight, legendary investor Michael Burry, famed for his eerily accurate prediction of the 2008 market crash, seized headlines once more in August.

Michael Burry's $1.6 billion bet against stock market is backfiring

BLOOMFIELD, Conn. , Sept. 25, 2023 /PRNewswire/ -- Cigna Healthcare, the health benefits provider of The Cigna Group (NYSE: CI), is investing $1 million in national and community-based organizations this fall to address food insecurity among older Americans.

Cigna Healthcare Takes Action To Fight Food Insecurity Among Seniors

Arch Capital

Devon Energy

GARP, or “Growth at a Reasonable Price,” is an investing strategy popularized by Wall Street legend Peter Lynch, who managed the Fidelity Magellan Fund (MUTF: FMAGX ). Peter Lynch's approach garnered a 29.2% annualized return during his time and beat the S&P 500 index for several years.

The Sweet Spot: 3 GARP Stocks You Can't Afford to Overlook

Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.

Here's Why Investors Should Retain Cigna (CI) Stock for Now

Ares Management

Coterra Energy

Deere & Company

Intuit

Mastercard

Old Dominion Freight Line

PulteGroup

This monthly series of articles focuses on DGI stocks likely to provide a high rate of dividend growth rather than a high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The article provides criteria for selecting high-growth dividend stocks. It offers a step-by-step guide on structuring a portfolio based on this strategy.

Our Top 10 Picks For Dividend Growth Stocks - September 2023

Cigna has demonstrated long-term earnings per share growth and has successfully navigated its post-merger phase with Express Scripts. The company's diversification across segments positions it to adapt to changing market dynamics and capitalize on emerging opportunities. Cigna benefits from an aging population, which increases the demand for healthcare services and offers a lucrative opportunity for the company.

Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape

CVS Health

GEO Group

MGM Resorts

Invesco QQQ

Stellantis N.V. 

Vital Energy Inc

On September 13, Finbold unveiled the latest insights into the enigmatic world of Michael Burry, the renowned ‘Big Short' investor.

Michael Burry's top 10 stock holdings as of September 14

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international consumer rights and securities litigation firm, announced that it has filed a class action lawsuit against Defendants The Cigna Group, Cigna Corporation and Cigna Life Insurance Company (collectively, the “Defendants”). The action, which was filed in the U.S. District Court for the District of Connecticut, captioned Van Pelt v. The Cigna Group, et al., Case No. 3:23-cv-01135, alleges that Defendants ha.

Scott+Scott Attorneys at Law LLP Files Consumer Class Action Against Cigna Corporation and Cigna Life Insurance Company

The new product from Cigna's (CI) Cigna Healthcare unit is likely to face significant demand in the global market.

Cigna's (CI) Unit Brings New Plan for Globally Mobile Seniors

Renowned investor Michael Burry, famous for his astute predictions, has garnered attention in the past due to his stock positions. Despite this interest, the ‘Big Short' investor has, in recent months, expressed a bearish position in the general stock market at some point advising investors to ‘sell'.

‘Big Short' Michael Burry's top 5 portfolio positions

News for Cigna Stock (CI)